Shares of Viking Therapeutics ( VKTX +6.55%), a clinical-stage biotech, have moved in exactly the wrong direction this year, ...
Kevin Warsh made his first entrance as Federal Reserve chair last week, and he's already changing things up. It has been the ...
Viking Therapeutics aspires to take market share from both Eli Lilly and Novo Nordisk, and it might succeed.
Netflix now trades at a price-to-earnings ratio of about 28, excluding the one-time $2.8 billion gain from the WBD ...
Shares of AbbVie ( ABBV +6.13%) climbed on Monday after the pharmaceutical giant struck a deal to acquire clinical-stage ...
For a $10,000 investment in SpaceX to turn into $1 million, the company's share price would have to increase by 100 times.
Following SpaceX's recent IPO, rumors are swirling the Elon Musk-led AI and space exploration company will soon merge with ...
The deal, valued at roughly $10.9 billion, obligates AbbVie to pay Apogee stockholders $135.11 per share in cash. The two ...
But in recent years, as demand for the vaccine declined, Moderna's earnings followed. The company suffered various setbacks, ...
Developing gas-fired power plants is a new business platform for Chevron. It will enable the global energy giant to leverage ...
In light of this momentum, the stock's dip seems to be nothing more than a healthy pullback before another leg higher. The ...
The data for long-term IPO returns spans the years 1975 to 2021. Over that time period, 9,195 IPOs were recorded. After three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results